Business
Initiation of Research Coverage
Initiation of Research Coverage.
About this update from Ironveld Plc
[{"type":"text","content":"\n \n \n \n RNS Number : 8288K\n Ironveld PLC\n 07 January 2021\n \n \n \n \n RNS Reach - This is a non-regulatory announcement.\n \n \n \n \n \n Ironveld Plc\n \n \n (\"Ironveld\" or the \"Company\")\n \n \n Initiation of Research Coverage\n \n \n Ironveld, the owner of a High Purity Iron (\"HPI\"), Vanadium and Titanium project (\"the Project\") located on the Northern Limb of the Bushveld Complex in Limpopo Province, South Africa company, announces the initiation of equity research on the Company by Align Research Limited.\n \n To download the full note please visit the following link:\n \n \n \n http://www.alignresearch.co.uk/cpt-company/ironveld/\n \n \n \n \n \n For further information, please contact:\n \n \n \n \n Ironveld plc\n Martin Eales, Chief Executive Officer\n \n \n \n \n \n \n c/o Blytheweigh\n +44 20 7138 3204\n \n \n \n \n \n Blytheweigh\n Tim Blythe / Megan Ray\n \n \n \n \n \n +44 20 7138 3204\n \n \n \n \n \n \n \n \n \n \n \n \n \n NOTES TO EDITORS\n \n \n \n \n \n Ironveld (IRON.LN) is the owner of Mining Rights over approximately 28 kilometres of outcropping Bushveld magnetite with a SAMREC compliant ore resource of some 56 million tons of ore grading 1,12% V2O5, 68,6% Fe2O3 and 14,7% TiO2.\n \n \n The Definitive Feasibility Study published in April 2014 confirms the project's viability to deliver a Vanadium slag product for which the company has an offtake agreement as well a High Purity Iron product which commands a premium in the market place and Titanium slag containing commercial grades of titanium.\n \n \n Ironveld is an AIM traded company. For further information on Ironveld please refer to www.ironveld.com.\n \n \n \n This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Sto...